Sandra Levy
ARTICLES BY THIS AUTHOR
- 5/28/2024
Walgreens lowers prices on 1,300 products
The company also plans to introduce a series of promotional campaigns, including the return of Walgreens popular myW Days in mid-July. - 5/28/2024
AAM applauds Senate Judiciary Committee efforts to protect patients, skinny labeling
The Association for Accessible Medicines submitted a formal statement for the record for the Senate Committee on the Judiciary hearing on drug pricing. - 5/27/2024
GoodRx offers discounts on branded, generic fertility medications
GoodRx offers discounts of up to 43% on fertility treatments, including savings on generic and brand-name medications used during every phase of the in vitro fertilization process. - 5/27/2024
ColoTest for colon cancer screening debuts at select Walmart locations
ColoTest, a new fecal immunochemical test for colon cancer screening, is available at 3,700 Walmart locations across the U.S. - 5/27/2024
Rite Aid reportedly close to deal on post-bankruptcy financing
Rite Aid is now close to a final deal with its lenders and expects to seek court approval of its bankruptcy restructuring in late June, per a Reuters report. - 5/27/2024
Walgreens to host “Walgreens En Tu Comunidad” health fair in Puerto Rico
Walgreens will host its first community health fair at a store in San Juan on Saturday, June 8. - 5/27/2024
Generics Access Project, patient advocacy orgs urge Congressional action to alleviate drug shortage crisis
The organizations sent a letter on May 21 to the Senate HELP and House Energy & Commerce leadership to stress congressional action to alleviate the worsening drug shortage crisis. - 5/23/2024
Nestlé intros Vital Pursuit Brand to support GLP-1 users, weight management
The new product line consists of portion-aligned foods with high protein and essential nutrients. - 5/23/2024
Ahold Delhaize to close select underperforming Stop & Shop grocery stores this year
Ahold Delhaize did not disclose how many Stop & Shop stores will close. - 5/23/2024
Alvotech, Dr. Reddy’s collaborate for biosimilar candidate to Prolia, Xgeva
Alvotech will develop and manufacture the product, and Dr. Reddy’s will register and commercialize it in the applicable markets.
